Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)

This Notice of Funding Opportunity (NOFO) supports exploratory research leading to proof of concept for the development of new technologies relevant to the NIGMS mission. Projects should entail a high degree of risk and/or novelty, and have a high future potential impact in biomedical research. The R21 mechanism is designed for early-stage technology development research that establishes the feasibility and proof of concept for innovative biomedical technologies. This funding opportunity encourages high-risk, high-reward projects that have the potential to transform biomedical research capabilities.